Volume 5, Issue 5, Pages (November 2015)

Slides:



Advertisements
Similar presentations
Ex Vivo Gene Therapy Using Patient iPSC-Derived NSCs Reverses Pathology in the Brain of a Homologous Mouse Model Tagan A. Griffin, Hayley C. Anderson,
Advertisements

Molecular Therapy - Nucleic Acids
Targeted Disruption of V600E-Mutant BRAF Gene by CRISPR-Cpf1
Volume 8, Issue 3, Pages (March 2017)
Volume 22, Issue 7, Pages (July 2015)
Expanding the Biologist’s Toolkit with CRISPR-Cas9
Volume 5, Issue 1, Pages (July 2015)
You Can Count on This: Barcoded Hematopoietic Stem Cells
In vivo optimization of the tagging approach using the Act5C model locus and flow cytometry-based quantification of the Act5C-GFP tagging success. In vivo.
Volume 9, Issue 5, Pages (November 2017)
Volume 154, Issue 2, Pages (July 2013)
Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency- Associated Genes  Steven Blinka, Michael H. Reimer, Kirthi Pulakanti,
Correction of a Genetic Disease in Mouse via Use of CRISPR-Cas9
Volume 11, Issue 1, Pages 1-3 (July 2018)
Volume 9, Issue 4, Pages (October 2017)
Mouse Genome Engineering via CRISPR-Cas9 for Study of Immune Function
Volume 22, Issue 1, Pages (January 2018)
Volume 7, Issue 1, Pages (April 2014)
Genome Engineering with CRISPR-Cas9 in the Mosquito Aedes aegypti
Molecular Therapy - Nucleic Acids
Volume 7, Issue 3, Pages (September 2016)
Molecular Therapy - Nucleic Acids
Volume 11, Issue 1, Pages (July 2018)
Volume 6, Issue 1, Pages (January 2016)
CRISPR genome-editing: A medical revolution
Volume 8, Issue 3, Pages (March 2017)
Volume 154, Issue 6, Pages (September 2013)
Volume 10, Issue 7, Pages (July 2017)
Simultaneous Reprogramming and Gene Correction of Patient Fibroblasts
Volume 10, Issue 6, Pages (June 2018)
Volume 153, Issue 4, Pages (May 2013)
Volume 7, Issue 1, Pages 1-10 (July 2016)
Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells
Volume 9, Issue 6, Pages (December 2017)
Volume 7, Issue 4, Pages (October 2016)
VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
Volume 9, Issue 5, Pages (November 2017)
TALEN Gene Knockouts Reveal No Requirement for the Conserved Human Shelterin Protein Rap1 in Telomere Protection and Length Regulation  Shaheen Kabir,
GFP to BFP Conversion: A Versatile Assay for the Quantification of CRISPR/Cas9- mediated Genome Editing  Astrid Glaser, Bradley McColl, Jim Vadolas  Molecular.
Volume 10, Issue 2, Pages (February 2018)
Volume 11, Issue 6, Pages (May 2015)
Volume 2, Issue 1, Pages (January 2014)
Volume 9, Issue 4, Pages (October 2017)
Volume 9, Issue 5, Pages (November 2017)
At Last: Gene Editing in Human Embryos to Understand Human Development
Molecular Therapy - Methods & Clinical Development
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Molecular Therapy - Nucleic Acids
Volume 153, Issue 4, Pages (May 2013)
Gene Targeting in Embryonic Stem Cells Scores a Knockout in Stockholm
Volume 15, Issue 3, Pages (April 2016)
Volume 25, Issue 2, Pages (February 2017)
Molecular Therapy - Nucleic Acids
Volume 23, Issue 3, Pages (March 2015)
Optimization of technical aspects for the genomic tagging approach.
Volume 12, Issue 4, Pages (July 2015)
Volume 9, Issue 4, Pages (October 2017)
Volume 17, Issue 5, Pages (October 2016)
Volume 9, Issue 5, Pages (November 2017)
Volume 16, Issue 2, Pages (February 2015)
Volume 9, Pages (November 2018)
Volume 2, Issue 6, Pages (June 2014)
Molecular Therapy - Nucleic Acids
Volume 26, Issue 11, Pages (November 2018)
Molecular Therapy - Nucleic Acids
Volume 9, Issue 4, Pages (April 2016)
DICER1 Is Essential for Self-Renewal of Human Embryonic Stem Cells
Volume 10, Issue 10, Pages (March 2015)
Volume 10, Issue 2, Pages (February 2018)
Volume 17, Issue 5, Pages (October 2016)
Presentation transcript:

Volume 5, Issue 5, Pages 908-917 (November 2015) Cloning-free CRISPR  Mandana Arbab, Sharanya Srinivasan, Tatsunori Hashimoto, Niels Geijsen, Richard I. Sherwood  Stem Cell Reports  Volume 5, Issue 5, Pages 908-917 (November 2015) DOI: 10.1016/j.stemcr.2015.09.022 Copyright © 2015 The Authors Terms and Conditions

Stem Cell Reports 2015 5, 908-917DOI: (10.1016/j.stemcr.2015.09.022) Copyright © 2015 The Authors Terms and Conditions

Figure 1 Simplified, Efficient Genome Editing Using scCRISPR (A) Schematic shows the scCRISPR/Cas9 process that occurs inside target cells. (B) Histograms show flow cytometric GFP fluorescence (x axis) in Hist1h3a mouse ESCs (left) after electroporation with Cas9 and plasmid sgRNA (second from left), sgPal1 plasmid alone (third from left), and sgPal1 plasmid and sgGFP homology fragment with standard-length arms (fourth from left). (C) Fluorescence microscopy shows GFP fluorescence in Hist1h3a-GFP mouse ESCs (left) after targeting with Cas9 and plasmid sgRNA (second from left) and sgPal1 plasmid and sgGFP homology fragment (third from left). (D) Histograms show flow cytometric GFP fluorescence (x axis) in Hist1h3a-GFP knockin mouse ESCs after electroporation with Cas9 and (from left to right) sgPal1, sgPal7, and sgPal8 plasmids together with a long sgGFP homology fragment. (E) MiSeq plasmid copy numbers per cell of sgPal1, sgGFP, and the three most frequently mismatched sgGFP species 96 hr after co-electroporation of mouse ESCs are shown. (F) Multiplexed mutation of GFP (x axis) and dsRed (y axis) in Hist1h3a-GFP Rosa26-dsRed mouse ESCs (left) after co-introduction of Cas9, sgPal1 plasmid, and sgGFP and sgDsRed long-armed homology fragments (right) is shown. See also Figure S1. Stem Cell Reports 2015 5, 908-917DOI: (10.1016/j.stemcr.2015.09.022) Copyright © 2015 The Authors Terms and Conditions

Figure 2 Efficient, Cloning-Free Knockin Transgenesis Using PCR-Amplified Homology Arms (A) Flow cytometric analysis shows efficient generation of Hist1h3a-GFP knockin mouse ESCs (y axis) using a PCR-amplified GFP fragment with 80 bp Hist1h3a homology arms and plasmid-based sgRNA (left) or scCRISPR sgRNA (right). (B) Fluorescence microscopy shows Hist1h3a-GFP mouse ESCs generated through scCRISPR-based knockin. (C) Flow cytometric analysis shows efficient generation of HIST1H2BJ-GFP knockin HUES2 human ESCs (y axis) with PCR-amplified homology arms and plasmid-based sgRNA (second from left) or scCRISPR-based sgRNA (right). Untargeted human ESC fluorescence is shown for comparison (left). (D) Fluorescence microscopy shows HIST1H2BJ-GFP human ESCs generated through plasmid-based (left) or scCRISPR-based (right) knockin. (E and F) Flow cytometric analysis shows that a cloning-free approach introducing a gBlock sgRNA and a PCR-amplified homology fragment leads to even more efficient generation of Hist1h3a-GFP knockin mouse ESCs (E) and HIST1H2BJ-GFP human ESCs (F). See also Figure S2. Stem Cell Reports 2015 5, 908-917DOI: (10.1016/j.stemcr.2015.09.022) Copyright © 2015 The Authors Terms and Conditions

Figure 3 An scCRISPR-Based NHEJ Gene Knockout Screen Improves HR Efficiency 3-Fold Hist1h3a-GFP knockin efficiency (y axis) is shown for 13 scCRISPR-generated bulk knockout lines of genes reported to play a role in NHEJ (x axis). Values and SDs are averaged from three independent biological experiments. A clonal double knockout line for Prkdc and Lig4 (red) exhibits 3-fold more efficient HR than wild-type mouse ESCs (dotted line). Stem Cell Reports 2015 5, 908-917DOI: (10.1016/j.stemcr.2015.09.022) Copyright © 2015 The Authors Terms and Conditions